Gregory Peter Kalemkerian
University of Michigan · 341 works · 11,908 citations · h-index 52
Top works
- High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study
- VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
- Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
- Lung Cancer in Women
- Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database.
- Small Cell Lung Cancer
- Treatment of Small Cell Lung Cancer
- Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis
- Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update
- Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
- NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018
- Tumor Lysis Syndrome in Small Cell Carcinoma and Other Solid Tumors
- Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
- Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non–Small-Cell Lung Cancer
- Total mutation burden (TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies.
- NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
- Impact of Race in Lung Cancer
- Lung Cancer in Patients < 50 Years of Age
- Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers
- Racial differences in lung cancer